Feng Deng

496 total citations
19 papers, 357 citations indexed

About

Feng Deng is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Nutrition and Dietetics. According to data from OpenAlex, Feng Deng has authored 19 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 5 papers in Pediatrics, Perinatology and Child Health and 4 papers in Nutrition and Dietetics. Recurrent topics in Feng Deng's work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Feng Deng is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Feng Deng collaborates with scholars based in Finland, United States and Netherlands. Feng Deng's co-authors include Heidi Kidron, Noora Sjöstedt, Mikko Niemi, Mikko Neuvonen, Arto Urtti, Anne M. Filppula, Anna‐Kaisa Rimpelä, Moshe Finel, Veli‐Pekka Ranta and Christoph Wenzel and has published in prestigious journals such as PLoS ONE, Pharmaceutical Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

Feng Deng

19 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Deng Finland 11 172 87 71 64 52 19 357
Edyta Szałek Poland 12 90 0.5× 114 1.3× 55 0.8× 55 0.9× 27 0.5× 67 415
Maxine Taylor United Kingdom 12 83 0.5× 111 1.3× 133 1.9× 75 1.2× 48 0.9× 14 436
Kaijing Zhao China 12 132 0.8× 97 1.1× 101 1.4× 34 0.5× 50 1.0× 22 314
Jignesh Patel United States 10 187 1.1× 110 1.3× 107 1.5× 22 0.3× 89 1.7× 12 462
Madhusudana R. Chaluvadi United States 6 173 1.0× 74 0.9× 154 2.2× 27 0.4× 71 1.4× 9 430
K. S. Cathcart United States 9 157 0.9× 206 2.4× 35 0.5× 33 0.5× 36 0.7× 9 441
F. J. Hollis United Kingdom 7 88 0.5× 166 1.9× 79 1.1× 26 0.4× 16 0.3× 8 345
Jin Ah Jung South Korea 11 100 0.6× 85 1.0× 77 1.1× 62 1.0× 65 1.3× 49 409
Danilo Wegner Germany 12 328 1.9× 120 1.4× 123 1.7× 48 0.8× 198 3.8× 19 582
C Madhu United States 12 98 0.6× 102 1.2× 155 2.2× 10 0.2× 34 0.7× 28 379

Countries citing papers authored by Feng Deng

Since Specialization
Citations

This map shows the geographic impact of Feng Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Deng more than expected).

Fields of papers citing papers by Feng Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Deng. The network helps show where Feng Deng may publish in the future.

Co-authorship network of co-authors of Feng Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Deng. A scholar is included among the top collaborators of Feng Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Deng. Feng Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Deng, Feng, et al.. (2025). Transport of statins by multidrug resistance-associated proteins 1 and 5. European Journal of Pharmaceutical Sciences. 209. 107070–107070. 1 indexed citations
2.
Deng, Feng, et al.. (2024). Ticagrelor modestly raises plasma riboflavin concentration in humans and inhibits riboflavin transport by BCRP and MRP4. Clinical Pharmacology & Therapeutics. 116(5). 1222–1226. 4 indexed citations
3.
Deng, Feng, Johanna Sistonen, Mikko Neuvonen, & Mikko Niemi. (2023). Inhibition of efflux transporters by poly ADP‐ribose polymerase inhibitors. Basic & Clinical Pharmacology & Toxicology. 133(4). 428–436. 2 indexed citations
4.
Filppula, Anne M., et al.. (2023). Rhabdomyolysis during concomitant ticagrelor and rosuvastatin: A breast cancer resistance protein‐mediated drug interaction?. British Journal of Clinical Pharmacology. 89(7). 2309–2315. 8 indexed citations
5.
Deng, Feng, Kaisa Huhtinen, Yilin Li, et al.. (2023). Toxicity and therapy outcome associations in LIG3, SLCO1B3, ABCB1, OPRM1 and GSTP1 in high‐grade serous ovarian cancer. Basic & Clinical Pharmacology & Toxicology. 132(6). 517–527. 2 indexed citations
6.
Deng, Feng, et al.. (2022). Novel inhibitors of breast cancer resistance protein (BCRP, ABCG2) among marketed drugs. European Journal of Pharmaceutical Sciences. 181. 106362–106362. 22 indexed citations
7.
Deng, Feng, et al.. (2022). The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates. Frontiers in Pharmacology. 12. 802539–802539. 60 indexed citations
8.
Deng, Feng, Mikko Neuvonen, Christoph Wenzel, et al.. (2021). Comparative Hepatic and Intestinal Efflux Transport of Statins. Drug Metabolism and Disposition. 49(9). 750–759. 48 indexed citations
9.
Filppula, Anne M., Feng Deng, Jenni Viinamäki, et al.. (2021). Comparative Hepatic and Intestinal Metabolism and Pharmacodynamics of Statins. Drug Metabolism and Disposition. 49(8). 658–667. 26 indexed citations
10.
11.
Deng, Feng, et al.. (2020). Food Additives as Inhibitors of Intestinal Drug Transporter OATP2B1. Molecular Pharmaceutics. 17(10). 3748–3758. 9 indexed citations
12.
Keskitalo, Jenni E., Aleksi Tornio, Outi Lapatto‐Reiniluoto, et al.. (2020). Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer Resistance Protein Substrate Rosuvastatin. Clinical and Translational Science. 13(6). 1236–1243. 26 indexed citations
13.
Rimpelä, Anna‐Kaisa, et al.. (2018). Pharmacokinetic Simulations of Intravitreal Biologicals: Aspects of Drug Delivery to the Posterior and Anterior Segments. Pharmaceutics. 11(1). 9–9. 39 indexed citations
14.
Sjöstedt, Noora, et al.. (2017). Interaction of Food Additives with Intestinal Efflux Transporters. Molecular Pharmaceutics. 14(11). 3824–3833. 24 indexed citations
15.
Deng, Feng, et al.. (2017). Efflux transport of estrogen glucuronides by human MRP2, MRP3, MRP4 and BCRP. The Journal of Steroid Biochemistry and Molecular Biology. 178. 99–107. 25 indexed citations
16.
Deng, Feng, et al.. (2017). A structure-activity relationship study of ABCC2 inhibitors. European Journal of Pharmaceutical Sciences. 103. 60–69. 8 indexed citations
17.
Deng, Feng, Noora Sjöstedt, & Heidi Kidron. (2016). The Effect of Albumin on MRP2 and BCRP in the Vesicular Transport Assay. PLoS ONE. 11(10). e0163886–e0163886. 17 indexed citations
18.
Deng, Feng, Veli‐Pekka Ranta, Heidi Kidron, & Arto Urtti. (2016). General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms. Pharmaceutical Research. 33(11). 2680–2690. 19 indexed citations
19.
Deng, Feng, et al.. (2014). Determination of levofloxacin in chicken tissue, manure and serum by self-ordered ring fluorescent microscopic imaging. Journal of Analytical Chemistry. 69(3). 283–289. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edyta Szałek Breakdown of academic impact, for papers by Maxine Taylor Breakdown of academic impact, for papers by Kaijing Zhao Breakdown of academic impact, for papers by Jignesh Patel Breakdown of academic impact, for papers by Madhusudana R. Chaluvadi Breakdown of academic impact, for papers by K. S. Cathcart Breakdown of academic impact, for papers by F. J. Hollis Breakdown of academic impact, for papers by Jin Ah Jung Breakdown of academic impact, for papers by Danilo Wegner Breakdown of academic impact, for papers by C Madhu
Rankless by CCL
2026